WallStSmart

Cencora Inc. (COR)vsQuipt Home Medical Corp (QIPT)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Cencora Inc. generates 127232% more annual revenue ($337.40B vs $264.97M). COR leads profitability with a 1.0% profit margin vs -0.0%. COR earns a higher WallStSmart Score of 62/100 (C+).

COR

Buy

62

out of 100

Grade: C+

Growth: 6.0Profit: 6.0Value: 5.3Quality: 3.8
Piotroski: 5/9

QIPT

Hold

40

out of 100

Grade: D

Growth: 5.3Profit: 2.5Value: 5.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CORSignificantly Overvalued (-85.6%)

Margin of Safety

-85.6%

Fair Value

$193.43

Current Price

$359.03

$165.60 premium

UndervaluedFair: $193.43Overvalued
QIPTUndervalued (+8.7%)

Margin of Safety

+8.7%

Fair Value

$3.90

Current Price

$3.65

$0.25 discount

UndervaluedFair: $3.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COR4 strengths · Avg: 8.8/10
Return on EquityProfitability
94.6%10/10

Every $100 of equity generates 95 in profit

Market CapQuality
$66.67B9/10

Large-cap with strong market position

PEG RatioValuation
0.778/10

Growing faster than its price suggests

Free Cash FlowQuality
$2.70B8/10

Generating 2.7B in free cash flow

QIPT1 strengths · Avg: 8.0/10
Price/BookValuation
1.6x8/10

Reasonable price relative to book value

Areas to Watch

COR4 concerns · Avg: 2.8/10
Price/BookValuation
18.6x4/10

Trading at 18.6x book value

Profit MarginProfitability
1.0%3/10

1.0% margin — thin

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Debt/EquityHealth
3.061/10

Elevated debt levels

QIPT4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
0.3%4/10

0.3% revenue growth

Market CapQuality
$162.30M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

Return on EquityProfitability
-0.1%2/10

ROE of -0.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : COR

The strongest argument for COR centers on Return on Equity, Market Cap, PEG Ratio. PEG of 0.77 suggests the stock is reasonably priced for its growth.

Bull Case : QIPT

The strongest argument for QIPT centers on Price/Book.

Bear Case : COR

The primary concerns for COR are Price/Book, Profit Margin, Operating Margin. Debt-to-equity of 3.06 is elevated, increasing financial risk. Thin 1.0% margins leave little buffer for downturns.

Bear Case : QIPT

The primary concerns for QIPT are Revenue Growth, Market Cap, Operating Margin.

Key Dynamics to Monitor

COR profiles as a value stock while QIPT is a turnaround play — different risk/reward profiles.

COR carries more volatility with a beta of 0.57 — expect wider price swings.

COR is growing revenue faster at 5.5% — sustainability is the question.

COR generates stronger free cash flow (2.7B), providing more financial flexibility.

Bottom Line

COR scores higher overall (62/100 vs 40/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cencora Inc.

HEALTHCARE · MEDICAL DISTRIBUTION · USA

CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.

Quipt Home Medical Corp

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Quipt Home Medical Corp. The company is headquartered in Wilder, Kentucky.

Want to dig deeper into these stocks?